Cargando…
Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity
Obesity favours the occurrence of locally disseminated prostate cancer in the periprostatic adipose tissue (PPAT) surrounding the prostate gland. Here we show that adipocytes from PPAT support the directed migration of prostate cancer cells and that this event is strongly promoted by obesity. This p...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729927/ https://www.ncbi.nlm.nih.gov/pubmed/26756352 http://dx.doi.org/10.1038/ncomms10230 |
_version_ | 1782412322492383232 |
---|---|
author | Laurent, Victor Guérard, Adrien Mazerolles, Catherine Le Gonidec, Sophie Toulet, Aurélie Nieto, Laurence Zaidi, Falek Majed, Bilal Garandeau, David Socrier, Youri Golzio, Muriel Cadoudal, Thomas Chaoui, Karima Dray, Cedric Monsarrat, Bernard Schiltz, Odile Wang, Yuan Yuan Couderc, Bettina Valet, Philippe Malavaud, Bernard Muller, Catherine |
author_facet | Laurent, Victor Guérard, Adrien Mazerolles, Catherine Le Gonidec, Sophie Toulet, Aurélie Nieto, Laurence Zaidi, Falek Majed, Bilal Garandeau, David Socrier, Youri Golzio, Muriel Cadoudal, Thomas Chaoui, Karima Dray, Cedric Monsarrat, Bernard Schiltz, Odile Wang, Yuan Yuan Couderc, Bettina Valet, Philippe Malavaud, Bernard Muller, Catherine |
author_sort | Laurent, Victor |
collection | PubMed |
description | Obesity favours the occurrence of locally disseminated prostate cancer in the periprostatic adipose tissue (PPAT) surrounding the prostate gland. Here we show that adipocytes from PPAT support the directed migration of prostate cancer cells and that this event is strongly promoted by obesity. This process is dependent on the secretion of the chemokine CCL7 by adipocytes, which diffuses from PPAT to the peripheral zone of the prostate, stimulating the migration of CCR3 expressing tumour cells. In obesity, higher secretion of CCL7 by adipocytes facilitates extraprostatic extension. The observed increase in migration associated with obesity is totally abrogated when the CCR3/CCL7 axis is inhibited. In human prostate cancer tumours, expression of the CCR3 receptor is associated with the occurrence of aggressive disease with extended local dissemination and a higher risk of biochemical recurrence, highlighting the potential benefit of CCR3 antagonists in the treatment of prostate cancer. |
format | Online Article Text |
id | pubmed-4729927 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-47299272016-03-04 Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity Laurent, Victor Guérard, Adrien Mazerolles, Catherine Le Gonidec, Sophie Toulet, Aurélie Nieto, Laurence Zaidi, Falek Majed, Bilal Garandeau, David Socrier, Youri Golzio, Muriel Cadoudal, Thomas Chaoui, Karima Dray, Cedric Monsarrat, Bernard Schiltz, Odile Wang, Yuan Yuan Couderc, Bettina Valet, Philippe Malavaud, Bernard Muller, Catherine Nat Commun Article Obesity favours the occurrence of locally disseminated prostate cancer in the periprostatic adipose tissue (PPAT) surrounding the prostate gland. Here we show that adipocytes from PPAT support the directed migration of prostate cancer cells and that this event is strongly promoted by obesity. This process is dependent on the secretion of the chemokine CCL7 by adipocytes, which diffuses from PPAT to the peripheral zone of the prostate, stimulating the migration of CCR3 expressing tumour cells. In obesity, higher secretion of CCL7 by adipocytes facilitates extraprostatic extension. The observed increase in migration associated with obesity is totally abrogated when the CCR3/CCL7 axis is inhibited. In human prostate cancer tumours, expression of the CCR3 receptor is associated with the occurrence of aggressive disease with extended local dissemination and a higher risk of biochemical recurrence, highlighting the potential benefit of CCR3 antagonists in the treatment of prostate cancer. Nature Publishing Group 2016-01-12 /pmc/articles/PMC4729927/ /pubmed/26756352 http://dx.doi.org/10.1038/ncomms10230 Text en Copyright © 2016, Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Laurent, Victor Guérard, Adrien Mazerolles, Catherine Le Gonidec, Sophie Toulet, Aurélie Nieto, Laurence Zaidi, Falek Majed, Bilal Garandeau, David Socrier, Youri Golzio, Muriel Cadoudal, Thomas Chaoui, Karima Dray, Cedric Monsarrat, Bernard Schiltz, Odile Wang, Yuan Yuan Couderc, Bettina Valet, Philippe Malavaud, Bernard Muller, Catherine Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity |
title | Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity |
title_full | Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity |
title_fullStr | Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity |
title_full_unstemmed | Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity |
title_short | Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity |
title_sort | periprostatic adipocytes act as a driving force for prostate cancer progression in obesity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729927/ https://www.ncbi.nlm.nih.gov/pubmed/26756352 http://dx.doi.org/10.1038/ncomms10230 |
work_keys_str_mv | AT laurentvictor periprostaticadipocytesactasadrivingforceforprostatecancerprogressioninobesity AT guerardadrien periprostaticadipocytesactasadrivingforceforprostatecancerprogressioninobesity AT mazerollescatherine periprostaticadipocytesactasadrivingforceforprostatecancerprogressioninobesity AT legonidecsophie periprostaticadipocytesactasadrivingforceforprostatecancerprogressioninobesity AT touletaurelie periprostaticadipocytesactasadrivingforceforprostatecancerprogressioninobesity AT nietolaurence periprostaticadipocytesactasadrivingforceforprostatecancerprogressioninobesity AT zaidifalek periprostaticadipocytesactasadrivingforceforprostatecancerprogressioninobesity AT majedbilal periprostaticadipocytesactasadrivingforceforprostatecancerprogressioninobesity AT garandeaudavid periprostaticadipocytesactasadrivingforceforprostatecancerprogressioninobesity AT socrieryouri periprostaticadipocytesactasadrivingforceforprostatecancerprogressioninobesity AT golziomuriel periprostaticadipocytesactasadrivingforceforprostatecancerprogressioninobesity AT cadoudalthomas periprostaticadipocytesactasadrivingforceforprostatecancerprogressioninobesity AT chaouikarima periprostaticadipocytesactasadrivingforceforprostatecancerprogressioninobesity AT draycedric periprostaticadipocytesactasadrivingforceforprostatecancerprogressioninobesity AT monsarratbernard periprostaticadipocytesactasadrivingforceforprostatecancerprogressioninobesity AT schiltzodile periprostaticadipocytesactasadrivingforceforprostatecancerprogressioninobesity AT wangyuanyuan periprostaticadipocytesactasadrivingforceforprostatecancerprogressioninobesity AT coudercbettina periprostaticadipocytesactasadrivingforceforprostatecancerprogressioninobesity AT valetphilippe periprostaticadipocytesactasadrivingforceforprostatecancerprogressioninobesity AT malavaudbernard periprostaticadipocytesactasadrivingforceforprostatecancerprogressioninobesity AT mullercatherine periprostaticadipocytesactasadrivingforceforprostatecancerprogressioninobesity |